Bg pattern

RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Rizatriptan Flas Dari Pharma 10 mg Oral Lyophilisates EFG

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What is Rizatriptan Flas Dari Pharma and what is it used for
  2. What you need to know before taking Rizatriptan Dari Pharma
  3. How to take Rizatriptan Flas Dari Pharma
  4. Possible side effects
  5. Storage of Rizatriptan Flas Dari Pharma
  6. Package Contents and Additional Information

1. What is Rizatriptan Flas Dari Pharma and what is it used for

Rizatriptan Flas Dari Pharma belongs to a group of medications called selective serotonin 5-HT1B/1D receptor agonists.

Rizatriptan is used to treat migraine headaches in adults.

Treatment with rizatriptan:

  • Reduces swelling of blood vessels surrounding the brain. This swelling causes migraine headache pain.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Rizatriptan Flas Dari Pharma

Do not take Rizatriptan Flas Dari Pharma

  • if you are allergic to rizatriptan benzoate or any of the other components of this medication (listed in section 6).
  • if you have moderately severe, severe, or uncontrolled high blood pressure.
  • if you have or have had heart problems, including heart attack or chest pain (angina), or have experienced signs related to heart disease.
  • if you have severe liver or kidney problems.
  • if you have had a stroke (CVA) or a transient ischemic attack (TIA).
  • if you have problems with obstruction in your arteries (peripheral vascular disease).
  • if you are taking monoamine oxidase inhibitors (MAOIs) such as moclobemide, phenelzine, tranylcypromine, or pargyline (medications for depression), or linezolid (an antibiotic), or if it has been less than two weeks since you stopped taking an MAOI.
  • if you are currently taking ergotamine-type medications, such as ergotamine or dihydroergotamine, to treat your migraine, or methysergide to prevent migraine attacks.
  • if you are taking any other medication of the same class, such as sumatriptan, naratriptan, or zolmitriptan, to treat your migraine (see also "Other medications and Rizatriptan Flas Dari Pharma" below).

If you are unsure whether any of the above applies to you, consult your doctor or pharmacist before taking Rizatriptan.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take rizatriptan if:

  • you have any of the following risk factors for heart disease: high blood pressure, diabetes, you are a smoker or use nicotine substitutes, your family has a history of heart disease, you are a man over 40 years old or a postmenopausal woman.
  • you have kidney or liver problems.
  • you have a specific problem with the way your heart beats (left bundle branch block).
  • you have or have had any allergies.
  • your headache is associated with dizziness, difficulty walking, lack of coordination, or weakness in your leg and arm.
  • you take herbal remedies containing St. John's Wort.
  • you have had allergic reactions such as swelling of the face, lips, tongue, and/or throat that can cause difficulty breathing or swallowing (angioedema).
  • you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine, or serotonin and norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine and duloxetine for depression.
  • you have had transient symptoms including pain and pressure in the chest.

If you take rizatriptan too frequently, it may cause you to develop chronic headaches. In such cases, you should contact your doctor, as you may need to stop taking rizatriptan.

Inform your doctor or pharmacist of all your symptoms. Your doctor will decide if you have migraines. You should only take Rizatriptan Flas Dari Pharma for a migraine attack.

Rizatriptan Flas Dari Pharma should not be used to treat other types of headaches that may be caused by more serious conditions.

Inform your doctor or pharmacist if you are using, have recently used, or might use any other medications. This includes herbal remedies and medications you normally take for migraines. This is because Rizatriptan Flas Dari Pharma may affect how some medications work, and other medications may also affect Rizatriptan Dari Pharma.

Other medications and Rizatriptan Flas Dari Pharma

Do not take rizatriptan:

  • if you are already taking a 5-HT1B/1D agonist (sometimes called "triptans"), such as sumatriptan, naratriptan, or zolmitriptan.
  • if you are taking a monoamine oxidase inhibitor (MAOI), such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline, or if it has been less than two weeks since you stopped taking an MAOI.
  • if you are taking ergotamine-type medications, such as ergotamine or dihydroergotamine, to treat your migraine.
  • if you are taking methysergide to prevent migraine attacks.

The medications mentioned above, when taken with rizatriptan, may increase the risk of side effects.

After taking rizatriptan, you should wait at least 6 hours before taking ergotamine-type medications, such as ergotamine, dihydroergotamine, or methysergide.

After taking ergotamine-type medications, you should wait at least 24 hours before taking rizatriptan.

Ask your doctor for instructions on how to take rizatriptan and information about the risks

  • if you are currently taking propranolol (see section 3 "How to take Rizatriptan Flas Dari Pharma").
  • if you are currently taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine, or serotonin and norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine and duloxetine for depression.

Inform your doctor or pharmacist if you are using, have recently used, or might use any other medications.

Taking Rizatriptan Flas Dari Pharma with food and drinks

Rizatriptan may take longer to work if you take it after meals. Although it is best to take it on an empty stomach, you can still take it even if you have eaten.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Available data on the safety of rizatriptan when used during the first three months of pregnancy do not indicate an increased risk of birth defects. It is unknown whether rizatriptan is harmful to the fetus when taken by a pregnant woman after the first three months of pregnancy.

If you are breastfeeding, you may postpone breastfeeding for 12 hours after treatment to avoid exposing your baby.

Children and Adolescents

The use of rizatriptan is not recommended in children under 18 years of age.

Use in Patients Over 65 Years of Age

There are no complete studies that evaluate the safety and efficacy of rizatriptan in patients over 65 years of age.

Driving and Using Machines

When taking rizatriptan, you may feel drowsy or dizzy. If this occurs, do not drive or use tools or machines.

Important Information About Some of the Components of Rizatriptan Dari Pharma

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

This medication contains 3.90 mg of aspartame in each tablet. Aspartame is a source of phenylalanine, which may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.

This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

3. How to Take Rizatriptan Flas Dari Pharma

Rizatriptan is used to treat migraine attacks. Take rizatriptan as soon as possible after your migraine headache starts. Do not use it to prevent an attack.

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

The recommended dose is 10 mg.

If you are currently taking propranolol or have kidney or liver problems, you should use the 5 mg dose of rizatriptan. You should wait at least 2 hours between taking propranolol and rizatriptan, up to a maximum of 2 doses in a 24-hour period.

If your migraine recurs within 24 hours

In some patients, migraine symptoms may recur within 24 hours. If your migraine recurs, you can take an additional dose of rizatriptan. You should always wait at least 2 hours between doses.

If after 2 hours you still have a migraine

If you do not respond to the first dose of rizatriptan during an attack, you should not take a second dose of rizatriptan for the treatment of the same attack. However, you may still respond to rizatriptan during the next attack.

Do not take more than 2 doses of rizatriptan in a 24-hour period (for example, do not take more than two 10 mg oral lyophilisates in a 24-hour period). You should always wait at least 2 hours between doses.

If your condition worsens, seek medical attention.

How to Administer Rizatriptan Flas Dari Pharma

  • Open the blister pack of the oral lyophilisate with dry hands.
  • Place the oral lyophilisate on your tongue, where it will dissolve so that it can be swallowed with your saliva.
  • The oral lyophilisate can be used in situations where liquids are not available or to avoid nausea and vomiting that may accompany taking tablets with liquids.

Rizatriptan is also available in tablets for taking with liquids.

If you take more Rizatriptan Flas Dari Pharma than you should

If you take more rizatriptan than you should, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 5620420, indicating the medication and the amount taken. It is recommended to bring the packaging and the package leaflet of the medication to the healthcare professional.

Signs of overdose may include dizziness, numbness, vomiting, fainting, and slow heart rate.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone gets them. The following side effects may occur with this medication.

In adult studies, the most commonly reported side effects were dizziness, drowsiness, and fatigue.

Frequent (affecting 1 to 10 in every 100 patients):

  • tingling sensation (paresthesia), headache, decreased skin sensitivity (hypoesthesia), decreased mental sharpness, insomnia.
  • rapid or irregular heartbeat (palpitations).
  • flushing (brief facial redness).
  • throat discomfort.
  • nausea, dry mouth, vomiting, diarrhea, indigestion (dyspepsia).
  • heaviness in parts of the body, neck pain, numbness.
  • abdominal or chest pain.

Uncommon (affecting 1 to 10 in every 1,000 patients):

  • bad taste in the mouth.
  • unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision, tremors, fainting (syncope).
  • confusion, nervousness.
  • high blood pressure (hypertension); thirst, hot flashes, sweating.
  • skin rash, itching, and hives (urticaria); swelling of the face, lips, tongue, or throat that can cause difficulty breathing or swallowing (angioedema), difficulty breathing (dyspnea).
  • stiffness in parts of the body, muscle weakness.
  • changes in heart rhythm or frequency (arrhythmia); alterations in the electrocardiogram (a test that records the physical activity of your heart), very rapid heart rate (tachycardia).
  • facial pain; muscle pain.

Rare (affecting 1 to 10 in every 10,000 patients):

  • breathing sounds.
  • allergic reaction (hypersensitivity), sudden and potentially life-threatening allergic reaction (anaphylaxis).
  • stroke (this usually occurs in patients with risk factors for heart or blood vessel disease, such as high blood pressure, diabetes, smoking, use of nicotine substitutes, family history of heart disease or stroke, men over 40 years old, postmenopausal women, and a specific problem with the way the heart beats, left bundle branch block).
  • slow heart rate (bradycardia).

Frequency Not Known (frequency cannot be estimated from available data)

  • heart attack, spasms of the blood vessels of the heart (these usually occur in patients with risk factors for heart or blood vessel disease, such as high blood pressure, diabetes, smoking, use of nicotine substitutes, family history of heart disease or stroke, men over 40 years old, postmenopausal women, and a specific problem with the way the heart beats, left bundle branch block).
  • a syndrome called "serotonin syndrome" that can cause side effects such as coma, unstable blood pressure, extremely high fever, lack of muscle coordination, agitation, and hallucinations.
  • severe skin peeling with or without fever (toxic epidermal necrolysis).
  • seizures (convulsions/fits).
  • contraction of blood vessels in the limbs, including cooling and numbness of hands and feet.
  • contraction of blood vessels in the colon (large intestine), which can cause abdominal pain.

Inform your doctor immediately if you have symptoms of an allergic reaction, serotonin syndrome, heart attack, or stroke.

Also, inform your doctor if you experience any symptoms that indicate an allergic reaction (such as rash or itching) after taking Rizatriptan Dari Pharma.

5. Storage of Rizatriptan Flas Dari Pharma

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date stated on the carton/outer packaging/foil/blister after "EXP". The expiration date is the last day of the month indicated.

Do not store above 30°C.

Medications should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Rizatriptan Flas Dari Pharma

  • The active ingredient is rizatriptan. Each oral lyophilisate contains 10 mg of rizatriptan, equivalent to 14.53 mg of rizatriptan benzoate.
    • The other components are: lactose monohydrate, microcrystalline cellulose (E460a), calcium silicate, crospovidone, aspartame (E951), peppermint flavor, anhydrous colloidal silica (E551), and magnesium stearate (E470b).

Appearance of the Product and Package Contents

The 10 mg oral lyophilisates are white, flat-faced, and round.

They are available in packs of 2 or 6 oral lyophilisates.

Marketing Authorization Holder:

Dari Pharma, S.L.U.

Gran Via Carles III, 98, 10th floor

08028 Barcelona

Spain

Manufacturer:

Neuraxpharm Pharmaceuticals, S.L.

Avenida de Barcelona, 69

08970, Sant Joan Despí, Barcelona

Spain

Date of Last Revision of this Package Leaflet:March 2025

Other Sources of Information:

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS

Discuss questions about RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS?
RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS?
The active ingredient in RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS is rizatriptan. This information helps identify medicines with the same composition but different brand names.
How much does RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS cost in pharmacies?
The average pharmacy price for RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS is around 8.8 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS?
RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS is manufactured by Dari Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RIZATRIPTAN FLAS DARI PHARMA 10 mg ORALLY DISINTEGRATING TABLETS?
Other medicines with the same active substance (rizatriptan) include MAXALT 10 mg TABLETS, MAXALT MAX 10 mg ORAL LYOPHILIZED, RIZATRIPTAN AUROVITAS 10 mg ORALLY DISINTEGRATING TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media